Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with Cancer

Biomarkers that predict likely response or resistance to specific therapies are critical in personalising treatment for cancer patients. Such biomarkers are now available for an increasing number of anti-cancer therapies, especially targeted therapy and immunotherapy. The gold-standard method for de...

Descripción completa

Detalles Bibliográficos
Autores principales: Duffy, Michael J., Crown, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779216/
https://www.ncbi.nlm.nih.gov/pubmed/35055414
http://dx.doi.org/10.3390/jpm12010099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779216/
https://www.ncbi.nlm.nih.gov/pubmed/35055414
http://dx.doi.org/10.3390/jpm12010099

Ejemplares similares